Inventor · disambiguated record
Harold V. Meyers
Also filed as: MEYERS HAROLD · MEYERS HAROLD V · MEYERS HAROLD VERNON
14 granted patents·4 pending applications·643 citations·filing 1990–2020
93Inventor score
Top patents by PatentIndex Score
18 records- 0196US5516797AImmunosuppressive compoundsVERTEX PHARMA·Filed 1994·Granted May 14, 1996·121 cites·8 claims
- 0296US5330993AImmunosuppressive compoundsVERTEX PHARMA·Filed 1991·Granted Jul 19, 1994·143 cites·1 claims
- 0396US5192773AImmunosuppressive compoundsVERTEX PHARMA·Filed 1990·Granted Mar 9, 1993·163 cites·10 claims
- 0491US7217794B2Compounds and methods for treatment of thrombosisDAIAMED INC·Filed 2004·Granted May 15, 2007·91 cites·6 claims
- 0590US10947220B2Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2020·Granted Mar 16, 2021·2 cites·7 claims
- 0690US10131637B2Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2014·Granted Nov 20, 2018·10 cites·6 claims
- 0789US5622970AImmunosuppressive compoundsVERTEX PHARMA·Filed 1995·Granted Apr 22, 1997·61 cites·10 claims
- 0886US5665774AImmunosuppressive compoundsFiled 1993·Granted Sep 9, 1997·42 cites·18 claims
- 0985US9682085B2Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2014·Granted Jun 20, 2017·4 cites·5 claims
- 1078US10899748B2Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2017·Granted Jan 26, 2021·2 cites·5 claims
- 1156US12274693B2Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) nano-formulation of compounds and methods of using the sameSHIFA BIOMEDICAL CORP·Filed 2019·Granted Apr 15, 2025·0 cites·30 claims
- 1255US2018079730A1Anti-pcsk9 compounds and methods for the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2017·Application pending·0 cites
- 1351US6080587AMethod for preparing and selecting pharmaceutically useful sulfur-bridged bi- and triaromatic ring compounds from a structurally diverse universal libraryLILLY CO ELI·Filed 1998·Granted Jun 27, 2000·4 cites·1 claims
- 1446US2016257672A1Functionalized furan-2-sulfonamides exhibiting endothelial lipase inhibitionTEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2014·Application pending·0 cites
- 1544US2008146811A1Compounds and Methods For Treatment of ThrombosisDENG HONGFENG·Filed 2005·Application pending·0 cites
- 1642US2016256467A1Anti-proprotein convertase subtilisin kexin type 9 (anti-pcsk9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2016·Application pending·0 cites
- 1737US10259804B2Anti-endothelial lipase compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2015·Granted Apr 16, 2019·0 cites·5 claims
- 1820US5492836AMethod for determining the structure of oligosaccharide linkages and automated instrumentation thereofUNIV COLUMBIA·Filed 1991·Granted Feb 20, 1996·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →